GSK plc (GSK)
London Exchange · UK · prices in GBX · close of 23 Oct 2026
Key indicators
| Last close | GBX 1,894.00 |
|---|---|
| 52-week range | 1,592.00 – 2,282.00 |
| Return, 1 month / 3 months | +0.4% / +0.3% |
| Return, 1 year / 3 years | +19.1% / +45.7% |
| Trend | Below its 200-day average |
| RSI (14) | 59 |
| Volatility (1 year) | 24.9% |
| Worst drawdown (1 year) | -21.5% |
| Average daily value traded | 11,654.21M GBX |
| Dividend yield | 3.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
GSK plc is a pharmaceutical company based in London that researches, develops and supplies prescription medicines and vaccines. Its work covers respiratory and infectious diseases, HIV, oncology and immunology, serving patients through healthcare providers, hospitals and health systems in many countries. The company also produces vaccines for children and adults, and it operates research and manufacturing sites internationally, with a focus on bringing new treatments from laboratory science into clinical use.
The shares are listed on the London Exchange in UK under the code GSK, and the price on this page is in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
GSK plc (GSK) trades on the London Exchange in UK. It last closed at GBX 1,894.00 on 23 October 2026.
Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 949 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 19.1% and over the last three months it rose 0.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 44 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -1.8% | ||
| From 52-week high | -16.5% | ||
| Momentum | 54 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 0.3% | ||
| 6-month return | -7.1% | ||
| 12-month return, skipping the last month | 18.6% | ||
| Stability (higher is calmer) | 72 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 24.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.5% | ||
| Liquidity | 100 · Strong | Trades actively. | |
| Average daily value traded | 11,654.21M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 72 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 3.6% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
Returns
| 1 week | +1.7% |
|---|---|
| 1 month | +0.4% |
| 3 months | +0.3% |
| 6 months | −7.1% |
| 1 year | +19.1% |
| 3 years | +45.7% |
| 5 years | +63.6% |
Signals
| 50-day / 200-day average | 1,846.37 / 1,928.05 |
|---|---|
| Golden / death cross (60 days) | Death, 37 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 54.56 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Aug 2026 | GBP 0.1700 |
| 14 May 2026 | GBP 0.1700 |
| 19 Feb 2026 | GBP 0.1800 |
| 13 Nov 2025 | GBP 0.1600 |
| 14 Aug 2025 | GBP 0.1600 |
| 15 May 2025 | GBP 0.1600 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.